Advertisement

Topics

Foundation for Mitochondrial Medicine (FMM) Company Profile

09:28 EDT 14th August 2018 | BioPortfolio


News Articles [1196 Associated News Articles listed on BioPortfolio]

[Review] Mitochondrial medicine in the omics era

Mitochondria are dynamic bioenergetic organelles whose maintenance requires around 1500 proteins from two genomes. Mutations in either the mitochondrial or nuclear genome can disrupt a plethora of cel...

Roche buys out rest of Foundation Medicine for $2.4bn

Roche has clearly seen significant potential in Foundation Medicine’s work in genomics to pay $2.4 billion to take complete ownership of the company. The big pharma company had already owned 58% of ...

NeuroVive's KL1333 Receives FDA Orphan Drug Designation for Treatment of Mitochondrial Diseases

LUND, Sweden, April 18 2018 /PRNewswire/ --NeuroVive Pharmaceutical AB(Nasdaq Stockholm: NVP) (OTCQX: NEVPF), the mitochondrial medicine company, today announced that it has been granted Orphan Dr...

In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine

Roche this morning agreed to acquire the part of Foundation Medicine it didn’t already own, another big vote of confidence in the broad tumor profiling panels that have struggled to gain traction bu...

Brain Mitochondrial Iron Found to Accumulate in Huntington’s Disease

University of Wyoming researchers say they have found that mice engineered to have Huntington's disease have an over-accumulation of iron in their mitochondria. Their work identifying a pathw...

Roche Acquires Rest of Foundational Medicine for $2.4B to Enhance Precision Medicine

Roche, today announced it has acquire all of the outstanding shares in Foundation Medicine that is not already owned by Roche and its affiliates for $2.4B, representing $137 per share. Together, the c...

Foundation Medicine Advances Patient Access to Precision Medicine; Pursues Regulatory Approval ...

-- Chugai to Commercialize Foundation Medicine’s Suite of Comprehensive Genomic Profiling (CGP) Services in Japan, Expanding Patient Access to Personalized Cancer Care -- Read mor...

Derfner Foundation funds novel research in regenerative medicine at Kessler Foundation

(Kessler Foundation) Kessler Foundation has received funding from the Derfner Foundation to support applying rehabilitation research to the area of regenerative medicine ('regenerative rehabilitation'...

Drugs and Medications [702 Associated Drugs and Medications listed on BioPortfolio]

Esika [Ventura Corporation (San Juan, P.R)]

ēsika 3-in-1 Pro Make Up Foundation SPF 20

Sheer cover mineral foundation [Guthy-Renker LLC]

Sheer Cover Mineral Foundation SPF-15

Cle de peau beaute silky foundation i [SHISEIDO CO., LTD.]

CPB Silky Cream Foundation I

Cle de peau beaute foundation i [SHISEIDO CO., LTD.]

cle de peau BEAUTE Cream Foundation I

Shiseido perfect refining foundation [SHISEIDO AMERICA INC.]

SHISEIDO Perfect Refining Foundation

PubMed Articles [2391 Associated PubMed Articles listed on BioPortfolio]

Foundation Year 2 doctors' reasons for leaving UK medicine: an in-depth analysis of decision-making using semistructured interviews.

To explore the reasons that doctors choose to leave UK medicine after their foundation year two posts.

Mitochondrial Ca signaling.

Mitochondrial Ca regulation is crucial for bioenergetics and cellular signaling. The mechanisms controlling mitochondrial calcium homeostasis have been recently unraveled with the discovery of mitocho...

The Florence Nightingale Foundation: developing nursing's leaders.

Ursula Ward, Chief Executive, Florence Nightingale Foundation, chiefexec@florence-nightingale-foundation.org.uk , describes the role of the foundation and its plans for the future.

Biochemical Assessment and Monitoring of Mitochondrial Disease.

Mitochondrial respiratory chain (MRC) disorders have a multifaceted clinical presentation and genetic origin[...].

Training-Induced Changes in Mitochondrial Content and Respiratory Function in Human Skeletal Muscle.

A sedentary lifestyle has been linked to a number of metabolic disorders that have been associated with sub-optimal mitochondrial characteristics and an increased risk of premature death. Endurance tr...

Clinical Trials [1780 Associated Clinical Trials listed on BioPortfolio]

Insulin Sensitizers on Mitochondrial ATP Production and Mitochondrial ATP Production and Mitochondrial Protein Synthesis on Insulin Resistant Type 2 Diabetes and Obesity

An association between insulin resistance and mitochondrial dysfunction has been observed in aging, T2D, and in offspring of patients with T2D. It remains to be determined whether pharmac...

Phase III Trial of Coenzyme Q10 in Mitochondrial Disease

Our central hypothesis is that oral CoQ10 is a safe and effective treatment for children with inborn errors of mitochondrial energy metabolism due to defects in specific respiratory chain ...

In and ex Vivo Mitochondrial Function of the Heart

It has been suggested that mitochondrial dysfunction might play a role in the development of diabetic cardiomyopathy. From animal studies, it has been suggested that an altered PPAR and PG...

The KHENERGY Study

Mitochondrial Diseases are rare, progressive, multi-system, often-early fatal disorders affecting both children and adults. KH176 is a novel chemical entity currently under development for...

The Effects of Exercise Versus Inactivity on People With Mitochondrial Muscle Disease

Mitochondrial myopathies include various inherited diseases that are caused by damage to the mitochondria, energy-producing structures that fuel the body's processes. The main symptoms are...

Companies [2412 Associated Companies listed on BioPortfolio]

The Foundation for Mitochondrial Medicine

The Foundation for Mitochondrial Medicine is a 501(c) (3) non-profit organization dedicated to supporting the development of the most promising research and treatments of the many...

The Alzheimer’s Drug Discovery Foundation (ADDF) and the Foundation for Mitochondrial Medicine (FMM)

Foundation for Mitochondrial Medicine (FMM)

Verne Mendel Medical Corp.

Verne Mendel Medical Corp. is a privately held biopharmaceutical company working on utilizing the highly mature knowledge base of the mitochondrial genome, developed by medical science during the past...

United Mitochondrial Disease Foundation

More Information about "Foundation for Mitochondrial Medicine (FMM)" on BioPortfolio

We have published hundreds of Foundation for Mitochondrial Medicine (FMM) news stories on BioPortfolio along with dozens of Foundation for Mitochondrial Medicine (FMM) Clinical Trials and PubMed Articles about Foundation for Mitochondrial Medicine (FMM) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Foundation for Mitochondrial Medicine (FMM) Companies in our database. You can also find out about relevant Foundation for Mitochondrial Medicine (FMM) Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record